Express News Service
HYDERABAD: An in-vitro study by researchers of University of Hyderabad, Centre for Cellular and Molecular Biology and a startup incubated at UoH - VINS Bio Products Limited, has shown that antibody fragments derived from horses might prove an effective therapy against Covid-19.
The study also indicates the therapy might work against the emerging variants of coronavirus as well.
A pre-print research paper on the study’s findings, ‘Development of Equine Immunoglobulin Fragment F(ab’)2 with High Neutralizing 2 Capability against SARS-CoV-2’, was recently uploaded on medrxiv.com.
In layman’s terms, the method involves immunisation of horse with inactivated novel coronavirus.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
Researchers based in India have demonstrated that horses inoculated with an inactivated dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are able to produce large amounts of strong antibodies that can neutralize multiple variants